Sarepta Therapeutics, Inc. (SRPT): R&D Expense
$1.52B
Year ended 2025-12-31
$789.44M
Trailing 12 months to 2026-06-30
+20.2%
3-year compound annual growth
+16.1%
5-year compound annual growth
+26.4%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.52B | +89.2% | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | $804.52M | -8.3% | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | $877.39M | 0.0% | 2026-03-02, From 2023-01-01 |
| 2022-12-31 | $877.09M | +13.7% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $771.18M | +6.8% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $722.34M | +28.8% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $560.91M | +39.6% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $401.84M | +141.0% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $166.71M | -11.5% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $188.27M | +28.6% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $146.39M | +55.4% | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | $94.23M | +29.2% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $72.91M | +39.1% | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | $52.40M | -21.6% | 2015-02-26, From 2012-01-01 |
| 2011-12-31 | $66.86M | +85.9% | 2014-03-03, From 2011-01-01 |
| 2010-12-31 | $35.97M | +47.5% | 2013-03-15, From 2010-01-01 |
| 2009-12-31 | $24.40M | n/a | 2012-03-13, From 2009-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $1.52B | +89.2% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $452.00M | n/m |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $455.25M | -14.8% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $186.18M | -2.4% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $550.00M | +14.3% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $24.55M | +3.5% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $921.93M | +23.4% |
| Alkermes plc. (ALKS) | 2025-12-31 | $323.96M | +32.1% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $1.32B | +17.2% |
Compare SRPT, RPRX, PTCT, AMRX side by side · Screen every company in Pharmaceutical Preparations ↗